Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-76.24M
↓ 15% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-66.17M
Historical baseline
PeriodValueYoY Change
TTM$-76.24M-317.9%
2024$-18.24M+83.2%
2023$-108.49M+1.1%
2022$-109.72M-39.7%
2021$-78.54M-13.4%
2020$-69.23M+14.1%
2019$-80.62M-150.8%
2018$-32.15M-44.3%
2017$-22.28M-